Candao, Sirangan D.

HRN: 21-65-58  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2022
CEFTRIAXONE 1G (VIAL)
07/30/2022
08/05/2022
IV
2g
Q24h
Acute Pyelonephtitis
Waiting Final Action 
08/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/02/2022
08/10/2022
IVT
4.5g
Q6
Hepatic Abscess Right
Waiting Final Action 
08/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2022
08/10/2022
IVT
500mg
Q6
Hepatic Abscess Right
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: